Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18Neoplasms 14Ovarian Neoplasms 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Lymphoma 6Neoplasm Metastasis 5Multiple Myeloma 5Hematologic Neoplasms 5Prostatic Neoplasms 4Leukemia 4Glioblastoma 4Fatigue 4Colorectal Neoplasms 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Sarcoma 3Pancreatic Neoplasms 3Myelodysplastic Syndromes 3Depression 3Anxiety Disorders 3Vaginal Neoplasms 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Pain 2Motor Activity 2Melanoma 2

Interventions

Cognitive Training 2Vitamin D 1Synbiotics 1Prebiotics 1Palliative Care 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Chemotherapy-Related Cognitive Impairment × Palliative Care × Clear all
NCT04586530 2026-01-21

TAMS

University of Pittsburgh

Phase NA Active not recruiting
220 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡